Fibroblast growth factor signalling in the diseased nervous system

L Klimaschewski, P Claus - Molecular Neurobiology, 2021 - Springer
Fibroblast growth factors (FGFs) act as key signalling molecules in brain development,
maintenance, and repair. They influence the intricate relationship between myelinating cells …

FGF/FGFR pathways in multiple sclerosis and in its disease models

R Rajendran, G Böttiger, C Stadelmann, S Karnati… - Cells, 2021 - mdpi.com
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system (CNS) affecting more than two million people worldwide. In MS …

BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes

M Yazdankhah, S Ghosh, P Shang, N Stepicheva… - Autophagy, 2021 - Taylor & Francis
Retinal ganglion cell axons are heavily myelinated (98%) and myelin damage in the optic
nerve (ON) severely affects vision. Understanding the molecular mechanism of …

Neural plasticity in multiple sclerosis: the functional and molecular background

DJ Ksiazek-Winiarek, P Szpakowski… - Neural …, 2015 - Wiley Online Library
Multiple sclerosis is an autoimmune neurodegenerative disorder resulting in motor
dysfunction and cognitive decline. The inflammatory and neurodegenerative changes seen …

Neurophysiology of synaptic functioning in multiple sclerosis

MS Bassi, F Mori, F Buttari, GA Marfia… - Clinical …, 2017 - Elsevier
Multiple sclerosis (MS) is an inflammatory immune-mediate disorder of the central nervous
system (CNS), primarily affecting the myelin sheath and followed by neurodegeneration …

Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders

CA Turner, E Eren-Koçak, EG Inui, SJ Watson… - Seminars in cell & …, 2016 - Elsevier
The role of the fibroblast growth factor (FGF) system in brain-related disorders has received
considerable attention in recent years. To understand the role of this system in neurological …

Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis

F Mori, S Rossi, S Piccinin, C Motta… - Journal of …, 2013 - Soc Neuroscience
Neuroplasticity is essential to prevent clinical worsening despite continuing neuronal loss in
several brain diseases, including multiple sclerosis (MS). The precise nature of the …

Inhibitor of PI3K/Akt signaling pathway small molecule promotes motor neuron differentiation of human endometrial stem cells cultured on electrospun biocomposite …

S Ebrahimi-Barough, E Hoveizi, M Yazdankhah… - Molecular …, 2017 - Springer
Small molecules as useful chemical tools can affect cell differentiation and even change cell
fate. It is demonstrated that LY294002, a small molecule inhibitor of phosphatidylinositol 3 …

New epidermal-growth-factor-related insights into the pathogenesis of multiple sclerosis: is it also epistemology?

G Scalabrino - Frontiers in neurology, 2021 - frontiersin.org
Recent findings showing that epidermal growth factor (EGF) is significantly decreased in the
cerebrospinal fluid (CSF) and spinal cord (SC) of living or deceased multiple sclerosis (MS) …

The role of growth factors as a therapeutic approach to demyelinating disease

Y Huang, CF Dreyfus - Experimental neurology, 2016 - Elsevier
A variety of growth factors are being explored as therapeutic agents relevant to the axonal
and oligodendroglial deficits that occur as a result of demyelinating lesions such as are …